New Research Published In Journal Of Biotechnology Highlights Utility Of InVitria’s Recombinant Human Leukemia Inhibitory Factor In Stem Cell Culture
1/6/2014 9:29:14 AM
FORT COLLINS, Colo.--(BUSINESS WIRE)--InVitria, a division of Ventria Bioscience, today announced publication of new research demonstrating that InVitria’s animal-component–free recombinant human leukemia inhibitory factor (rhLIF) is comparable to traditional sources of recombinant LIF for the maintenance of pluripotent mouse embryonic stem cells (ESC) in culture.
Help employers find you! Check out all the jobs and post your resume.
comments powered by